Definition:Specified disease insurance
🏥 Specified disease insurance is a type of supplemental health insurance that pays a benefit upon the diagnosis of, or treatment for, one or more diseases explicitly named in the policy — most commonly cancer, heart attack, stroke, and end-stage renal disease, though policy schedules vary by insurer and jurisdiction. Unlike comprehensive health insurance, which covers a broad spectrum of medical conditions, specified disease policies are narrow in scope and typically pay fixed lump-sum or scheduled benefits directly to the policyholder, regardless of actual medical expenses incurred. This product occupies a distinct niche in markets worldwide — particularly popular in the United States as a voluntary workplace benefit, widely sold in Japan where "tokutei shippei" cancer policies represent a major product category, and available across parts of Southeast Asia and Africa where comprehensive medical coverage may be limited or unaffordable.
📋 The structure of a specified disease policy centers on a defined schedule of covered conditions and corresponding benefit amounts. When a policyholder receives a qualifying diagnosis confirmed by medical documentation, the insurer pays the contractual benefit — which might be a single lump sum, a per-treatment amount, or a combination of initial diagnosis benefits and ongoing treatment payments. Underwriting is typically simplified compared to major medical insurance, often involving a health questionnaire and pre-existing condition exclusions rather than full medical underwriting. Premiums tend to be relatively modest, making these policies accessible for individual purchase or employer-sponsored voluntary benefit programs. In the United States, specified disease policies are generally regulated as limited benefit or supplemental products and are not considered minimum essential coverage under the Affordable Care Act, while in Japan, standalone cancer insurance represents one of the largest individual life-and-health product segments, with carriers like Aflac and Japan Post Insurance having built substantial portfolios around it.
💰 The value proposition of specified disease insurance rests on financial protection against the indirect and out-of-pocket costs that accompany a serious illness — lost income during treatment, travel to specialized medical facilities, deductibles and copayments on primary health plans, and everyday household expenses that continue even when the policyholder cannot work. For insurers, these products offer attractive persistency characteristics and relatively predictable claims experience once the covered disease incidence rates are well understood, though emerging medical advances that improve survival rates can alter claims patterns over time. Critics note that the narrow coverage scope means policyholders face no benefit if they develop a condition not listed in the policy, which is why regulators in several markets require clear disclosure that specified disease insurance does not replace comprehensive health coverage. For the insurance industry more broadly, these products illustrate how targeted, easy-to-understand benefit structures can reach populations underserved by traditional indemnity health plans.
Related concepts: